Profilo
Tsvetelina Pencheva Hoang formerly worked at Bellicum Pharmaceuticals, Inc., as Director-Translational Research from 2015 to 2018, The Phi Beta Kappa Society, as Member, and Marker Therapeutics, Inc., as Vice President-Research & Development from 2018 to 2024.
Dr. Hoang received her doctorate degree from The Johns Hopkins University and undergraduate degree and graduate degree from Yale University.
Precedenti posizioni note di Tsvetelina Hoang
| Società | Posizione | Fine |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2024 |
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2018 |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Corporate Officer/Principal | - |
Formazione di Tsvetelina Hoang
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Marker Therapeutics, Inc.
Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Phi Beta Kappa Society
The Phi Beta Kappa Society Miscellaneous Commercial ServicesCommercial Services Operates as a organisation for liberal arts and science education | Commercial Services |
















